Knoll Capital Management as of March 31, 2019
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 17 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 29.3 | $39M | 750k | 51.47 | |
| Corbus Pharmaceuticals Hldgs | 26.3 | $35M | 5.0M | 6.95 | |
| Abeona Therapeutics | 13.2 | $17M | 2.4M | 7.36 | |
| Krystal Biotech (KRYS) | 5.2 | $6.9M | 210k | 32.90 | |
| Blackstone | 4.1 | $5.4M | 153k | 34.97 | |
| Altria (MO) | 3.9 | $5.2M | 90k | 57.43 | |
| Dowdupont | 3.6 | $4.8M | 90k | 53.31 | |
| Aldeyra Therapeutics (ALDX) | 3.3 | $4.4M | 484k | 9.03 | |
| Kranesh Bosera Msci China A cmn (KBA) | 2.3 | $3.1M | 96k | 31.89 | |
| Electrocore | 2.1 | $2.8M | 397k | 7.00 | |
| Anavex Life Sciences (AVXL) | 1.7 | $2.2M | 724k | 3.05 | |
| Entera Bio (ENTX) | 1.6 | $2.1M | 476k | 4.33 | |
| Galmed Pharmaceuticals | 1.3 | $1.7M | 206k | 8.17 | |
| Eiger Biopharmaceuticals | 0.8 | $1.1M | 75k | 13.98 | |
| Soligenix | 0.6 | $771k | 838k | 0.92 | |
| Molecular Templates | 0.5 | $662k | 114k | 5.81 | |
| Lipocine | 0.1 | $116k | 50k | 2.32 |
